Literature DB >> 20345974

An imbalance in mucosal cytokine profile causes transient intestinal inflammation following an animal's first exposure to faecal bacteria and antigens.

B C Sydora1, S M MacFarlane, M Lupicki, A L Dmytrash, L A Dieleman, R N Fedorak.   

Abstract

Intestinal microflora play a critical role in the initiation and perpetuation of chronic inflammatory bowel diseases. In genetically susceptible hosts, bacterial colonization results in rapid-onset chronic intestinal inflammation. Nevertheless, the intestinal and systemic immune response to faecal bacteria and antigen exposure into a sterile intestinal lumen of a post-weaned animal with a mature immune system are not understood clearly. This study examined the effects of faecal bacteria and antigen exposure on the intestinal mucosal and systemic immune system in healthy axenic mice. Axenic wild-type mice were inoculated orally with a crude faecal slurry solution derived from conventionally raised mice and were analysed prior to and then at days 3, 7, 14 and 28 post-treatment. Ingestion of faecal slurry resulted in a transient, early onset of proinflammatory interferon (IFN)-gamma, tumour necrosis factor (TNF)-alpha and interleukin (IL)-17 response that was maximal at day 3. In contrast, the transient release of the anti-inflammatory cytokines IL-10 and IL-4 occurred later and was maximal at day 7. Both responses subsided by day 14. This early cytokine imbalance was associated with a brief rise in colonic and caecal histopathological injury score at day 7. The bacterial antigen-specific systemic response was found to follow the intestinal immune response with a maximal release of both pro- and anti-inflammatory cytokines at day 7. Thus, first exposure of healthy axenic wild-type mice to normal faecal flora and antigens results in an early proinflammatory cytokine response and transient colonic inflammation that then resolves in conjunction with a subsequent anti-inflammatory cytokine profile.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20345974      PMCID: PMC2940164          DOI: 10.1111/j.1365-2249.2010.04140.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Non-pathogenic bacteria modulate colonic epithelial gene expression in germ-free mice.

Authors:  K Fukushima; H Ogawa; K Takahashi; H Naito; Y Funayama; T Kitayama; H Yonezawa; I Sasaki
Journal:  Scand J Gastroenterol       Date:  2003-06       Impact factor: 2.423

Review 2.  Recent knowledge of the strict anaerobes of the gut.

Authors:  K L Hughes
Journal:  Aust Vet J       Date:  1972-09       Impact factor: 1.281

3.  Cytolytic activity of intestinal intraepithelial lymphocytes in germ-free mice is strain dependent and determined by T cells expressing gamma delta T-cell antigen receptors.

Authors:  M Kawaguchi; M Nanno; Y Umesaki; S Matsumoto; Y Okada; Z Cai; T Shimamura; Y Matsuoka; M Ohwaki; H Ishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

4.  T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans.

Authors:  R Duchmann; E May; M Heike; P Knolle; M Neurath; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

5.  Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when.

Authors:  R Balfour Sartor
Journal:  Curr Opin Gastroenterol       Date:  2003-07       Impact factor: 3.287

6.  Localization of gamma/delta T cells to the intestinal epithelium is independent of normal microbial colonization.

Authors:  A Bandeira; T Mota-Santos; S Itohara; S Degermann; C Heusser; S Tonegawa; A Coutinho
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

7.  Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.

Authors:  Lydia A Haile; Reinhard von Wasielewski; Jaba Gamrekelashvili; Christine Krüger; Oliver Bachmann; Astrid M Westendorf; Jan Buer; Roland Liblau; Michael P Manns; Firouzeh Korangy; Tim F Greten
Journal:  Gastroenterology       Date:  2008-06-12       Impact factor: 22.682

8.  Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut.

Authors:  K E Shroff; K Meslin; J J Cebra
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 9.  Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology.

Authors:  P G Falk; L V Hooper; T Midtvedt; J I Gordon
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

10.  Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

Authors:  R Duchmann; I Kaiser; E Hermann; W Mayet; K Ewe; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

View more
  7 in total

1.  Intravenous injection of endogenous microbial components abrogates DSS-induced colitis.

Authors:  Beate C Sydora; Eric J Albert; Rae R Foshaug; Jason S G Doyle; Thomas A Churchill; Richard N Fedorak
Journal:  Dig Dis Sci       Date:  2011-09-01       Impact factor: 3.199

2.  Effect of solar particle event radiation on gastrointestinal tract bacterial translocation and immune activation.

Authors:  Houping Ni; Klara Balint; Yu Zhou; Daila S Gridley; Casey Maks; Ann R Kennedy; Drew Weissman
Journal:  Radiat Res       Date:  2011-02-04       Impact factor: 2.841

3.  Microbiota maintain colonic homeostasis by activating TLR2/MyD88/PI3K signaling in IL-10-producing regulatory B cells.

Authors:  Yoshiyuki Mishima; Akihiko Oka; Bo Liu; Jeremy W Herzog; Chang Soo Eun; Ting-Jia Fan; Emily Bulik-Sullivan; Ian M Carroll; Jonathan J Hansen; Liang Chen; Justin E Wilson; Nancy C Fisher; Jenny Py Ting; Tomonori Nochi; Angela Wahl; J Victor Garcia; Christopher L Karp; R Balfour Sartor
Journal:  J Clin Invest       Date:  2019-06-18       Impact factor: 14.808

4.  Extracellular Vesicles Derived from Bone Marrow Mesenchymal Stem Cells Protect against Experimental Colitis via Attenuating Colon Inflammation, Oxidative Stress and Apoptosis.

Authors:  Jia Yang; Xing-Xing Liu; Heng Fan; Qing Tang; Zhe-Xing Shou; Dong-Mei Zuo; Zhou Zou; Meng Xu; Qian-Yun Chen; Ying Peng; Shuang-Jiao Deng; Yu-Jin Liu
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

5.  Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice.

Authors:  Wei-Syun Hu; Peramaiyan Rajendran; Bor-Show Tzang; Yu-Lan Yeh; Chia-Yao Shen; Ray-Jade Chen; Tsung-Jung Ho; Viswanadha Vijaya Padma; Yi-Hsing Chen; Chih-Yang Huang
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

6.  Oral administration of Lactobacillus plantarum 06CC2 prevents experimental colitis in mice via an anti‑inflammatory response.

Authors:  Akihito Tanaka; Shuji Kanmura; Yuko Morinaga; Katsuto Kawabata; Shiho Arima; Fumisato Sasaki; Yuichirou Nasu; Shiroh Tanoue; Shinichi Hashimoto; Masahiko Takeshita; Shiro Takeda; Akio Ido
Journal:  Mol Med Rep       Date:  2020-01-09       Impact factor: 2.952

7.  Cross-talk between E. coli strains and a human colorectal adenocarcinoma-derived cell line.

Authors:  Xuan He; Darya O Mishchuk; Jigna Shah; Bart C Weimer; Carolyn M Slupsky
Journal:  Sci Rep       Date:  2013-12-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.